UPB-101 + Placebo

Phase 1Completed
0 watching 0 views this week๐Ÿ’ค Quiet
25
Hype Score

Development Stage

โœ“
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Asthma

Conditions

Asthma

Trial Timeline

Jul 8, 2022 โ†’ Oct 5, 2023

About UPB-101 + Placebo

UPB-101 + Placebo is a phase 1 stage product being developed by Upstream Bio for Asthma. The current trial status is completed. This product is registered under clinical trial identifier NCT05448651. Target conditions include Asthma.

Hype Score Breakdown

Clinical
10
Activity
5
Company
2
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT05448651Phase 1Completed